ArcticZymes Technologies ASA: Minutes from Annual General Meeting 2021
(Tromsø 20. May 2021) ArcticZymes Technologies ASA (OSE:AZT) has today, 20. May held the Annual General Meeting
Please find the minutes attached.
All matters were resolved as proposed in the notice for the Annual General Meeting.
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
For further information, please contact:
Børge Sørvoll
CFO
+47 952 90187
borge.sorvoll@arcticzymes.com
About ArcticZymes Technologies ASA
ArcticZymes Technologies is a Norwegian life sciences company focused on the development, manufacturing and commercialization of novel recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and therapeutics. Listed on the Oslo Stock Exchange since 2005 originally under the [Biotec] ticker, as Biotec Pharmacon. The company rebranded as ArcticZymes Technologies in 2020 under the [AZT] ticker. Its headquarters are based in Tromsø, Norway, at the SIVA Innovation Centre. ArcticZymes Technologies' IP and capabilities are protected via a large portfolio of patents. For more information, please visit the website: www.arcticzymes.com.